# EDGAR Filing Document

**Accession Number:** 0001711933
**File Stem:** 0001104659-25-068879
**Filing Date:** 2025-7
**Character Count:** 2787
**Document Hash:** 2a1aa65bb033ac26cec3de247a0cd811
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-25-068879.hdr.sgml**: 20250718

**ACCESSION NUMBER**: 0001104659-25-068879

**CONFORMED SUBMISSION TYPE**: 15-12G

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20250718

**DATE AS OF CHANGE**: 20250718

**EFFECTIVENESS DATE**: 20250718

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Akoya Biosciences, Inc.
- **CENTRAL INDEX KEY:** 0001711933
- **STANDARD INDUSTRIAL CLASSIFICATION:** LABORATORY ANALYTICAL INSTRUMENTS [3826]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 475586242
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 15-12G
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40344
- **FILM NUMBER:** 251132749

**BUSINESS ADDRESS:**
- **STREET 1:** 100 CAMPUS DRIVE
- **STREET 2:** 6TH FLOOR
- **CITY:** MARLBOROUGH
- **STATE:** MA
- **ZIP:** 01762
- **BUSINESS PHONE:** 855.896.8401

**MAIL ADDRESS:**
- **STREET 1:** 100 CAMPUS DRIVE
- **STREET 2:** 6TH FLOOR
- **CITY:** MARLBOROUGH
- **STATE:** MA
- **ZIP:** 01762

**UNITED STATES<br> SECURITIES AND EXCHANGE COMMISSION**<br> **WASHINGTON, D.C. 20549**

<br> **FORM 15**

**CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER<br> SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION<br> OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE<br> SECURITIES EXCHANGE ACT OF 1934.**

**Commission File Number: 001-40344**

**Akoya Biosciences, Inc.**

(Exact name of registrant as specified in its charter)

**100 Campus Drive, 6th Floor**

**Marlborough, Massachusetts 01752**

**(855) 896-8401**

(Address, including zip code, and telephone number, including area code, of registrant's principal executive offices)

**Common Stock, $0.00001 Par Value**<br> (Title of class of securities covered by this Form)

**None**<br> (Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

---

| | |
|:---|:---|
| Rule 12g-4(a)(1) | ⌧ |
| Rule 12g-4(a)(2) | ¨ |
| Rule 12h-3(b)(1)(i) | ⌧ |
| Rule 12h-3(b)(1)(ii) | ◻ |
| Rule 15d-6 | ◻ |
| Rule 15d-22(b) | ◻ |

---

Approximate number of holders of record as of the certification or notice date: One

Pursuant to the requirements of the Securities Exchange Act of 1934, Akoya Biosciences, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

---

| | | |
|:---|:---|:---|
|  | **AKOYA BIOSCIENCES, INC.** | **AKOYA BIOSCIENCES, INC.** |
| Date: July 18, 2025 | By: | /s/ Vandana Sriram |
|  | Name: | Vandana Sriram |
|  | Title: | Treasurer |

---